Yu Xia, Director at Summit Therapeutics Inc. (SMMT), bought 1,067,234 shares at $18.74 ($20.0M) on 2025-10-21, disclosed to the SEC on 2025-10-23.
Open-market purchase of $20.0M SMMT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.74 | 533,617 | $10.0M | 50.0% |
| 2 | $18.74 | 533,617 | $10.0M | 50.0% |
| Total | $18.74 avg | 1,067,234 | $20.0M | 100% |